| |
Eledoisin |
|
|
| Cat. No. |
Size |
Price |
Figures |
|---|
RP10456-1 mg
| 1 mg | $ 23.75 | HPLC: 20060721145616 (PDF)
MS: 20060721145555 (PDF)
MSDS: 20080728032659 (PDF)
STRUCTURE:
Zoom
References:
- Messinger DI, et al. Identification and characterization of a tachykinin-containing neuroendocrine organ in the commissural ganglion of the crab Cancer productus. J Exp Biol. Sep 2005; 208(17): 3303-3319.
- Dike A, Cowsik SM. Membrane-Induced Structure of Scyliorhinin I: A Dual NK1/NK2 Agonist. Biophys J. May 2005; 88(5): 3592-3600.
- Wu HE, et al. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord. J Pharmacol Exp Ther. Jul 2004; 310(1): 240-246.
|
|---|
| Full Name | | Sequence
(three-letter code) | {pGLU}{PRO}{SER}{LYS}{ASP}{ALA}{PHE}{ILE}{GLY}{LEU}
{MET}-NH2 |
|---|
| C-Terminal | NH2 |
|---|
| Description | Eledoisin, an undecapeptide of mollusk origin, with the sequence pGlu-Pro-Ser-Lys-Asp-Ala-Phe-Ile-Gly-Leu-Met-NH2, is a member of the tachykinin family of neuropeptides. It was first isolated from the posterior salivary glands of two mollusk species, Eledone muschata and E. aldovandi, belonging to Cephalopoda. Other tachykinins from nonmammalian sources include kassinin and physalaemin. These peptides exhibit a wide and complex spectrum of pharmacological and physiological activities such as powerful vasodilation, hypertensive action, and stimulation of extravascular smooth muscle. |
|---|
| Formula | C54H85N13O15S1 |
|---|
| M.W. | 1188.4 |
|---|
| Cas | 69-25-0 |
|---|
| Purity | > 95% |
|---|
| Storage | Store eledoisin at -20°C.
|
| * For Non-Clinical Research Use Only *
Our customer service is available 24 hours a day, Monday through Friday. You may contact us any time for assistance.
|
|
